RIM
GBT

RS Investment Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

RS Investment Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-317,800
Closed -$13.4M – 385
2015
Q3 		$13.4M Buy
+317,800
New +$15M 0.12% 215

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

RS Investment Management's GBT Position: Q4 2015 in Review

RS Investment Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2015, closing a stake of 317,800 shares — an estimated $13.4M sold.

RS Investment Management first reported a position in GBT in Q3 2015 and held it in 1 quarter. The position peaked at $13.4M in Q3 2015. 68 funds tracked by Wall St. Rank hold GBT as of Q4 2015.

  • RS Investment Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2015 after selling out during the quarter.
  • RS Investment Management sold 317,800 Global Blood Therapeutics, Inc. shares in Q4 2015, an estimated $13.4M.
  • RS Investment Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 1 quarter.
  • RS Investment Management's Global Blood Therapeutics, Inc. position peaked at $13.4M in Q3 2015.
  • 68 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2015.

Based on RS Investment Management's 13F filing for Q4 2015, filed 11 Feb 2016.